These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23651025)

  • 41. Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation.
    Ng FL; Holt DW; MacPhee IA
    Expert Opin Pharmacother; 2007 Sep; 8(13):2045-58. PubMed ID: 17714059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacogenomics and beyond! Customized pharmacotherapy for solid organ transplant recipients.
    Lemke A; Wright J; May H
    Pharmacotherapy; 2023 Jul; 43(7):596-608. PubMed ID: 36999337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenetic differences and drug-drug interactions in immunosuppressive therapy.
    Warrington JS; Shaw LM
    Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):487-503. PubMed ID: 16863457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacogenetics of immunosuppressants: progress, pitfalls and promises.
    Cattaneo D; Baldelli S; Perico N
    Am J Transplant; 2008 Jul; 8(7):1374-83. PubMed ID: 18510642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Re: Transplantation between monozygotic twins: how identical are they?
    Goldfarb DA
    J Urol; 2015 Jan; 193(1):230. PubMed ID: 25523681
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
    Nguyen TT; Pearson RA; Mohamed ME; Schladt DP; Berglund D; Rivers Z; Skaar DJ; Wu B; Guan W; van Setten J; Keating BJ; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
    J Clin Pharm Ther; 2020 Dec; 45(6):1457-1465. PubMed ID: 32662547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacogenetics and immunosuppressor drugs: impact and clinical interest in transplantation].
    Marquet P; Djebli N; Picard N
    Ann Pharm Fr; 2007 Nov; 65(6):382-9. PubMed ID: 18079670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacogenetics in kidney transplantation: recent updates and potential clinical applications.
    Elens L; Hesselink DA; van Schaik RH; van Gelder T
    Mol Diagn Ther; 2012 Dec; 16(6):331-45. PubMed ID: 23192462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic drug monitoring in pediatric renal transplantation.
    Weber LT
    Pediatr Nephrol; 2015 Feb; 30(2):253-65. PubMed ID: 24763544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacogenetics and pharmacogenomics of immunosuppressive agents: perspective for individualized therapy.
    Cattaneo D; Tankiewicz A; Merlini S; Perico N; Remuzzi G
    Per Med; 2004 Dec; 1(1):53-62. PubMed ID: 29793227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Applied pharmacogenetic].
    Thervet É
    Nephrol Ther; 2016 Apr; 12 Suppl 1():S99-S103. PubMed ID: 26972091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of genetics in drug dosing.
    Ware N
    Pediatr Nephrol; 2012 Sep; 27(9):1489-98. PubMed ID: 22358188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What is the appropriate management, including drug therapy, for epilepsy in a child with a renal transplant?
    Robinson RO
    Pediatr Nephrol; 1993 Aug; 7(4):364. PubMed ID: 8398642
    [No Abstract]   [Full Text] [Related]  

  • 54. From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy.
    Cattaneo D; Perico N; Remuzzi G
    Am J Transplant; 2004 Mar; 4(3):299-310. PubMed ID: 14961981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy.
    Danesi R; Mosca M; Boggi U; Mosca F; Del Tacca M
    Mol Med Today; 2000 Dec; 6(12):475-82. PubMed ID: 11099953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of pharmacogenomics in pediatric renal transplant recipients.
    Medeiros M; Castañeda-Hernández G; Ross CJ; Carleton BC
    Front Genet; 2015; 6():41. PubMed ID: 25741362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transplantation genetics: current status and prospects.
    Almoguera B; Shaked A; Keating BJ
    Am J Transplant; 2014 Apr; 14(4):764-78. PubMed ID: 24618335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Introduction to genetic processes in transplantation.
    Santiago-Sim T; Colosimo S; Powner DJ
    Prog Transplant; 2012 Jun; 22(2):192-8; quiz 199. PubMed ID: 22878077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The emerging role of gene polymorphisms determining outcome after solid-organ transplantation.
    Filler G; Hocher B
    Pediatr Transplant; 2002 Feb; 6(1):12-4. PubMed ID: 11906636
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation.
    Turolo S; Edefonti A; Syren ML; Montini G
    J Clin Med; 2023 Jul; 12(13):. PubMed ID: 37445489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.